Composition and imaging methods for pharmacokinetic and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A61B 1/00 (2006.01) C12N 15/63 (2006.01)

Patent

CA 2474138

A halogen-labeled gene therapy construct that includes halogen labeled nucleic acids, methods for preparing a halogenated gene therapy construct, and methods for in vivo imaging of the same. Also provided are methods for non-invasive drug detection in a subject using a labeled antibody that recognizes a heterologous antigen conjugated to, encoded by, or otherwise associated with the drug.

L'invention porte sur un gène hybride obtenu par thérapie génique marqué par un halogène et comprenant des acides nucléiques marqués par un halogène, sur des procédés de préparation du gène hybride halogéné ainsi que sur des procédés d'imagerie <i>in vivo</i> dudit gène. Font également l'objet de cette invention des procédés de détection de médicaments chez un patient utilisant un anticorps marqué reconnaissant un antigène hétérologue conjugué à, codé par ou sinon associé audit médicament.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition and imaging methods for pharmacokinetic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and imaging methods for pharmacokinetic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and imaging methods for pharmacokinetic and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1668431

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.